Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
VIA Pharmaceuticals, Inc. is a drug development company focused on compounds that target inflammation in the blood vessel wall, as an innovative approach to treatment of cardiovascular disease. Inflammation in the blood vessel wall recently has been shown to have a fundamental role in all stages of atherosclerosis, and in precipitating heart attacks and other acute cardiovascular events. VIA scientists are experts in the field of vascular (blood vessel) inflammation and cardiovascular disease. The company’s management team has extensive pharmaceutical industry experience in successful drug development and regulatory approval. VIA is building a pipeline of clinical-stage small-molecule drugs that intervene in vascular ( www.viapharmaceuticals.com )
VIA Pharmaceuticals , Inc.
750 Battery Street Suite 330
San Francisco, California 94111
USA
Tel: (415) 283-2200
Fax: (415) 283-2201